Patent · US Active

Antibodies that bind amyloid oligomers

US9895429B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventor

Rakez Kayed · Galveston, US

Key dates

Filing date	Jul 28, 2015
Grant date	Feb 20, 2018
Priority date	—
Expiry date	Jul 28, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2835
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the invention are directed to compositions and methods related to immunogenic compositions comprising the amino acid sequence of SEQ ID NO:1 and amyloid oligomer specific antibodies that specifically bind an oligomer comprising such a peptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.